Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshington Innov Regulatory News (ASHI)

Share Price Information for Ashington Innov (ASHI)

Share Price is delayed by 15 minutes
Get Live Data
0.85    0.00 (0.00%)
Bid:
0.70
Ask:
1.00
Spread: 0.30 (42.857%)
Market Cap: £617.08k
ASHI Live PriceLast checked at - London Stock Exchange

Intraday Ashington Innov Share Chart

Retrospective applications and corrections

31 Jul 2024 07:00

RNS Number : 4730Y
Ashington Innovation PLC
31 July 2024
 

The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014, as retained as part of the law of England and Wales. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

Press Release

 

31 July 2024

Ashington Innovation plc

 

("Ashington" or "the Company")

 

Retrospective applications and corrections

 

Further to the announcement made on 20 December 2023, Ashington Innovation plc (LSE: ASHI; FSE: 6FW), a special purpose acquisition company ("SPAC"), clarifies that retrospective applications are being made for the 1,200,000 ordinary shares referenced in that announcement, to be admitted to the Equity Shares (Shell Companies) category of the Official List and to trading on the Main Market of the London Stock Exchange plc, which is expected to occur on or around 8.00am on 5 August 2024 ("Admission").

 

The following corrections are being made to the announcement made on 25 July 2024:

 

·

the 10,000,000 ordinary shares referenced in that announcement will be admitted to the Equity Shares (Shell Companies) category, which is expected to occur on or around 8.00am on 1 August 2024; and

·

upon Admission, the resulting total number of issued shares and the total number of voting rights in the Company will be 72,597,900.

 

For further information please contact:

Ashington Innovation plc

Jason Smart

Non-Executive Director

via Tancredi +44 207 887 7633

Tancredi Intelligent Communication

Media Relations

Helen Humphrey

Charlie Hobbs

Neha Dhakal

ashington@tancredigroup.com

+44 7449 226 720

+44 7897 557 112

+44 7915 035 294

 

About Ashington Innovation plc

 

Ashington Innovation plc is a special purpose acquisition company (SPAC), formed with the intention of acquiring businesses operating in the technology sector, in particular the financial services technology and deep technology sectors.

 

The Company believes that in the increasingly fast-changing global environment there will be an abundance of opportunities to acquire existing businesses in the technology sector, and in particular businesses that possess and utilise proprietary technologies and own applicable intellectual property.

 

The Company is not limited to any specific geographic region in identifying its target companies. www.ashingtoninnovation.com.

 

Forward-looking statements:

This announcement may contain "forward-looking" statements and information relating to the Company. These statements are based on the beliefs of Company management, as well as assumptions made by and information currently available to Company management. The Company does not undertake to update forward‐looking statements or forward‐looking information, except as required by law.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCQKKBNOBKDBON
Date   Source Headline
26th May 20264:45 pmRNSNotice of Annual General Meeting
30th Apr 20267:00 amRNSAnnual results
5th Dec 20255:20 pmRNSNotice of General Meeting
30th Sep 20257:00 amRNSInterim results
22nd Jul 20251:40 pmRNSResults of General Meeting
3rd Jul 20259:55 amRNSNotice of GM
9th Jun 20254:20 pmRNSResults of Annual General Meeting
15th May 20254:00 pmRNSNotice of Annual General Meeting
30th Apr 20257:00 amRNSAnnual Report
4th Oct 20246:15 pmRNSTR-1: Standard notification of major holdings
4th Oct 20246:15 pmRNSTR-1: Standard notification of major holdings
30th Sep 20247:00 amRNSInterim results
15th Aug 20244:20 pmRNSTR-1: Standard notification of major holdings
31st Jul 20247:00 amRNSRetrospective applications and corrections
25th Jul 20247:00 amRNSFundraise
17th Jun 202412:50 pmRNSResults of Annual General Meeting
24th May 20247:00 amRNSPosting of Annual Report and Notice of AGM
30th Apr 20246:19 pmRNSAnnual results
25th Jan 20247:30 amRNSRestoration - Ashington Innovation PLC
24th Jan 20247:00 amRNSTermination of Proposed Reverse Takeover
12th Jan 202412:30 pmRNSResults of Annual General Meeting
20th Dec 20232:00 pmRNSPosting of Annual Report and Notice of AGM
20th Dec 20231:15 pmRNSIssue of Equity
20th Dec 20237:00 amRNSAppointment of New Auditors
8th Nov 20233:30 pmRNSBoard changes
16th Oct 20237:00 amRNSAppointment of Non-Executive Director
5th Sep 20237:00 amRNSUpdate on Cell Therapy and Calon Discussions
24th Aug 20237:00 amRNSHeads of Terms Signed for the Acquisition of Calon
21st Aug 20237:00 amRNSDual Listing on the Frankfurt Stock Exchange
17th Aug 20238:10 amRNSHeads of Terms Signed
17th Aug 20237:30 amRNSSuspension - Ashington Innovation PLC
16th Aug 20237:00 amRNSBoard Change
9th Aug 202312:26 pmRNSChange of Accounting Reference Date
6th Jun 20238:01 amRNSAshington - Admission to trading on the LSE

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.